QIAGEN Announces Supply Agreement to Provide Preanalytical Solutions to Osmetech Molecular Diagnostics
QIAGEN GmbH, a wholly-owned subsidiary of QIAGEN N.V. and Osmetech molecular diagnostics., a division of Osmetech plc announced that they have entered into a distribution agreement. Pursuant to this agreement, Osmetech will incorporate certain preanalytical consumables and technologies from QIAGEN into Osmetech microarray-based solutions for use in diagnostic and research applications. QIAGEN's proprietary preanalytical technologies provide unmatched reproducibility and efficiency in molecular diagnostics applications.
Most read news
Other news from the department business & finance

Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.